The association between vascular function-related genes and age at natural menopause

Menopause

Volumn 15, Issue 3, 2008, Pages 511-516

  Van Disseldorp, Jeroen ^a   Broekmans, Frank J ^a   Peeters, Petra H ^a   Fauser, Bart C ^a   Van Der Schouw, Yvonne T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clotting factor; Genetics; Menopause; Single nucleotide polymorphism (SNP)

Indexed keywords

APOLIPOPROTEIN E2; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; FEMALE; GENE DELETION; GENE INSERTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LIFESTYLE MODIFICATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PARITY; POINT MUTATION; POSTMENOPAUSE; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGING; APOLIPOPROTEIN E2; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 43249116909     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31814cec52     Document Type: Article

References (55)

1. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342-1346.
2. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
3. Torgerson DJ, Thomas RE, Reid DM. Mothers and daughters menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Biol 1997;74:63-66.
4. Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998;83:1875-1880.
5. Treloar SA, Do KA, Martin NG. Genetic influences on the age at menopause. Lancet 1998;352:1084-1085.
6. de Bruin JP, Bovenhuis H, van Noord PA, et al. The role of genetic factors in age at natural menopause. Hum Reprod 2001;16:2014-2018.
7. van Asselt KM, Kok HS, Pearson PL, et al. Heritability of menopausal age in mothers and daughters. Fertil Steril 2004;82:1348-1351.
8. Tarin JJ. Aetiology of age-associated aneuploidy: a mechanism based on the 'free radical theory of ageing.' Hum Reprod 1995;10:1563-1565.
9. Gaulden ME. Maternal age effect: the enigma of Down syndrome and other trisomic conditions. Mutat Res 1992;296:69-88.
10. Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997;12:1047-1055.
11. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006;13:265-279.
12. Snowdon DA, Kane RL, Beeson WL, et al. Is early natural menopause a biologic marker of health and aging? Am J Public Health 1989;79:709-714.
13. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996;347:714-718.
14. Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol 1998;8:229-235.
15. Kok HS, van Asselt KM, van der Schouw YT, et al. Heart disease risk determines menopausal age rather than the reverse. J Am Coll Cardiol 2006;47:1976-1983.
16. Tempfer CB, Riener EK, Keck C, et al. Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women. Menopause 2005;12:325-330.
17. van Noord PA, Dubas JS, Dorland M, Boersma H, te Velde E. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril 1997;68:95-102.
18. Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000;46:28-49.
19. Kurjak A, Kupesic S. Ovarian senescence and its significance on uterine and ovarian perfusion. Fertil Steril 1995;64:532-537.
20. Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 1998;33:891-896.
21. van Asselt KM, Kok HS, Peeters PH, et al. Factor V Leiden mutation accelerates the onset of natural menopause. Menopause 2003;10:477-481.
22. Pripp U, Eriksson-Berg M, Orth-Gomer K, Schenck-Gustafsson K, Landgren BM. Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women? Gend Med 2005;2:88-95.
23. Boker LK, van Noord PA, van der Schouw YT, et al. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol 2001;17:1047-1053.
24. Zivelin A, Rosenberg N, Faier S, et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 1998;92:1119-1124.
25. De Stefano V, Martinelli I, Mannucci PM, et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med 1999;341:801-806.
26. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
27. Majerus PW. Human genetics: bad blood by mutation. Nature 1994;369:14-15.
28. Jimenez-Boj E, Schuttrumpf J, Forberg E, Watzke HH, Huber K. The decanucleotide polymorphism in the factor VII promoter predicts factor VII plasma levels but not the risk of acute coronary syndromes. J Thromb Thrombolysis 2000;10:23-28.
29. Di Castelnuovo A, D'Orazio A, Amore C, Falanga A, Donati MB, Iacoviello L. The decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of familial myocardial infarction. Thromb Res 2000;98:9-17.
30. Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000;343:774-780.
31. Emi M, Wu LL, Robertson MA, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988;3:373-379.
32. Sullivan PM, Mezdour H, Quarfordt SH, Maeda N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J Clin Invest 1998;102:130-135.
33. Cheng S, Grow MA, Pallaud C, et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res 1999;9:936-949.
34. Sing CF, Rothman ED. A consideration of the chi-square test of Hardy-Weinberg equilibrium in a non-multinomial situation. Adv Appl Probabil 1976;8:22-23.
35. Hefler LA, Worda C, Huber JC, Tempfer CB. A polymorphism of the Nos3 gene and age at natural menopause. Fertil Steril 2002;78:1184-1186.
36. Worda C, Walch K, Sator M, et al. The influence of Nos3 polymorphisms on age at menarche and natural menopause. Maturitas 2004;49:157-162.
37. Riener EK, Keck C, Worda C, Hefler LA, Tempfer CB. Body mass index but not a polymorphism of the interleukin-1 receptor antagonist (IL-1 RA) gene is associated with age at natural menopause. Gynecol Obstet Invest 2004;58:117-120.
38. Zenzes MT, Wang P, Casper RF. Cigarette smoking may affect meiotic maturation of human oocytes. Hum Reprod 1995;10:3213-3217.
39. Westhoff C, Murphy P, Heller D. Predictors of ovarian follicle number. Fertil Steril 2000;74:624-628.
40. Matikainen T, Perez GI, Jurisicova A, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001;28:355-360.
41. Windham GC, Mitchell P, Anderson M, Lasley BL. Cigarette smoking and effects on hormone function in premenopausal women. Environ Health Perspect 2005;113:1285-1290.
42. Detmar J, Rabaglino T, Taniuchi Y, et al. Embryonic loss due to exposure to polycyclic aromatic hydrocarbons is mediated by Bax. Apoptosis 2006;11:1413-1425.
43. Motejlek K, Palluch F, Neulen J, Grummer R. Smoking impairs angiogenesis during maturation of human oocytes. Fertil Steril 2006;86:186-191.
44. Paszkowski T, Clarke RN, Hornstein MD. Smoking induces oxidative stress inside the Graafian follicle. Hum Reprod 2002;17:921-925.
45. Tiboni GM, Bucciarelli T, Giampietro F, Sulpizio M, Di Ilio C. Influence of cigarette smoking on vitamin E, vitamin A, β-carotene and lycopene concentrations in human pre-ovulatory follicular fluid. Int J Immunopathol Pharmacol 2004;17:389-393.
46. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen FE. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-985.
47. de Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, van Leeuwen FE. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 2003;18:1544-1552.
48. Nikolaou D, Lavery S, Turner C, Margara R, Trew G. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod 2002;17:1106-1111.
49. Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F, Volpe A. Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril 2000;74:809-812.
50. Ozturk O, Bhattacharya S, Saridogan E, Jauniaux E, Templeton A. Role of utero-ovarian vascular impedance: predictor of ongoing pregnancy in an IVF-embryo transfer programme. Reprod Biomed Online 2004;9:299-305.
51. Merce LT, Bau S, Barco MJ, et al. Assessment of the ovarian volume, number and volume of follicles and ovarian vascularity by three-dimensional ultrasonography and power Doppler angiography on the HCG day to predict the outcome in IVF/ICSI cycles. Hum Reprod 2006;21:1218-1226.
52. Woldringh GH, Frunt MH, Kremer JA, Spaanderman ME. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Hum Reprod 2006;21:2948-2954.
53. Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998;70:240-245.
54. Tallo CP, Vohr B, Oh W, Rubin LP, Seifer DB, Haning RV Jr. Maternal and neonatal morbidity associated with in vitro fertilization. J Pediatr 1995;127:794-800.
55. Arnal JF, Douin-Echinard V, Brouchet L, et al. Understanding the oestrogen action in experimental and clinical atherosclerosis. Fundam Clin Pharmacol 2006;20:539-548.